Marfan syndrome is an inherited disorder that affects the connective tissue of the body (“What is Marfan Syndrome?” n.d.). The connective tissue plays a vital role in supported the tendons, heart valves, cartilage, blood vessels, and more parts of the body (“Connective Tissue,” n.d.). “What is Marfan Syndrome?” (n.d.) explains that the condition has no cure, and those who have it lack strength in their connective tissue, affecting their bone, eyes, skin, nervous system, and lungs. Furthermore, Marfan syndrome is common, and it is imperative to understand how the body is affected by it, the symptoms, and the treatment of this condition.
Marfan’s syndrome is a disorder that is inherited. Mutations that are passed from parent to child are hereditary mutations or germ line mutations. The syndrome is named after Antoine Marfan, a French pediatrician who described the condition. Marfan’s syndrome is an autosomal dominant disorder as portrayed in the image above. Parents have a 50% chance of passing the mutation to their offspring. Marfan’s syndrome affects the connective tissues that are in the body which means that it affects the body’s proteins. Fibrillin-1 is a protein that is integral in normally functioning connective tissue. Marfan’s Syndrome is caused by a FBN1 mutation that leads to misfolding of fibrillin-1. According to ("Marfan Syndrome." - Genetics Home Reference. N.p., 7 Apr. 2014. Web. 14 Apr. 2014), a gene mutation is a permanent change in the DNA sequence that makes up a gene. The protein that increases when someone has Marfan’s syndrome is TGFB (transforming growth factor beta). The protein increases because TGF-β causes problems in connective tissues throughout the body, which creates the features and m...
Marfan syndrome is an autosomal dominant disorder resulting from mutations in the gene fibrillin-1 (FBN1) found on chromosome 15 (McKusick V, O'Neill M, 2013). At least 140 different mutations of this gene have been recorded since 2008 (Frey R, Lutwick L, 2009). The FBN1 gene regulates the manufacturing of the fibrillin-1 protein that assists in constructing fibrous filaments which are present in portions of the fibers in connective tissue (Frey R, Lutwick L, 2009). Those filaments manage the discharge of growth factors or protein molecules which prompt the reproduction and growth of cells (Frey R, Lutwick L, 2009). In healthy individuals, the filaments discharge growth factors at the right moment but those who have Marfan syndrome are faced with the dilemma of growth factors being discharged too soon. The early release of growth factors results in fragile connective tissue and the uncommonly lengthy limbs of those with the disorder.
Marfan’s syndrome is a disease where the connective tissue in a person’s joints are more elastic than a normal persons. Marfans syndrome can also be called arachnodactyly meaning “spider” which comes from the Greek word, arachne. It was named this since all patients tend to have long limbs. The chromosome that is affected by this disease is called Chromosome 15, which was discovered by scientists in 1991. And research is currently underway to find out the cause of these mutations in the body. Most patients are tall, thin, have long and narrow faces, longer limbs with a protruding or sunken in breastbone, crowded teeth, flat feet and most also have scoliosis. Their connective tissue is affected and becomes abnormal. Connective tissue is classified as tendons,
Marfan Syndrome (MFS) is a disorder of the connective tissue, which holds all parts of the body together and helps control how the body grows. Since connective tissue is found throughout the body it can affect several different areas, such as the cardiovascular system, musculoskeletal system, and the ocular system, and sometimes the integumentary system, and lungs can be affected. About 1 in 5,000 people have MFS including men and women of all races and ethnic groups.
Neurofibromatosis (NF)
Neu-ro-fi-bro-ma-to-sis (Merriam Webster)
Heidi Pasion
March 24, 2014
Exploring the Internet
BTEC 1510-51
Mousumi Munmun
What is Neurofibromatosis?
Neurofibromatosis (NF) is a genetic disorder of the nervous system.
Roorcyk et al. reported that the disease is caused by the missense mutations occur in COLEC11 and MASP1 gene. These genes are involved in lectin complement pathway in humans. They studied the disease in eleven families of affected children in which four of them are from consanguineous family. They managed to show that different mutations in COLEC11 or MASP1 cause the 3MC syndrome. They further used zebra fish model to strengthen their findings. Moreover, they analyzed CL-K1, the byproduct of COLEC11 pathway to study neural crest cells migration in affected patients. Most of their observations were supported by Sirmaci et al. 2010 and Kerstjens-Frederikse et al. 2005.
Muscular dystrophy (DMD) is a widespread genetic disease that affects approximately 1 in 3000 males (MDA | Muscular Dystrophy Association, n.d.). This disease results from a mutation in the gene dystrophin, a sarcolemmal protein rich in skeletal and cardiac muscle cells. Dystrophin is naturally absent in DMD.
People with Marfan Syndrome are born with it. And they need as many special care as any other medical condition, this condition does not make them less than any other human being. They feel pain, love, and have hope to get better in their life condition and be as happy as they can. The science has made further improvements to provide for those who were born with the condition to have a better and healthy life, and a less painful treatment. As we may know there are possibilities of developing Marfan syndrome without having familiar record of the disease, it has nothing to do with race or skin color or even social and economic position. To see individuals who have Marfan Syndrome from a sociological perspective makes wonder if they need certain
Fragile X Syndrome causes a range of developmental problems including, learning disabilities and cognitive impairment. These problems include physical features from, large ears, long face, soft skin and large testicles (called “macroorchidism”) in post-pubertal males. Not every with the FM1 gene has symptoms of Fragile X Syndrome, because the body may still be able to make FMRP. A few things that affect how much FMRP that can makes includes, the size of the mutation, the number of cells that have can make include the size of mutation, the number of cells that have mutations and lastly whether or not someone is female. These factors determine how much FMRP protein is made and whether or not signs and symptoms of Fragile X Syndrome will be mild or